Together, the in vivo observation and the clinical validation revealed the critical role of CPT1C in facilitating tumor progression of BLBC and the significance of CPT1C as the prognostic indicator for patients with BLBC, reflecting our in vitro results that CPT1C contributes to EMT-associated phenotypes, migration, invasion, and cancer stemness in BLBC cells. This evidence concerns the gene CPT1C and cancer.